论文信息 - Intracranial and whole-body response of ceritinib in ALK inhibitor-naïve and previously ALK inhibitor-treated patients with ALK-rearranged non-small-cell lung cancer ( NSCLC ) : updated results from the phase 1 , multicentre , open-label ASCEND-1 trial - 字舞流文

Intracranial and whole-body response of ceritinib in ALK inhibitor-naïve and previously ALK inhibitor-treated patients with ALK-rearranged non-small-cell lung cancer ( NSCLC ) : updated results from the phase 1 , multicentre , open-label ASCEND-1 trial

Michael Thomas | A. Shaw | Gregory Riely | E. Felip | B. Solomon | J. Wolf | A. Santoro | R. Mehra | D. Camidge | Dong-Wan Kim | D. Tan | L. Chow | J. Vansteenkiste | Sunil Sharma | M. Schuler | Geoffrey Liu | S. Sutradhar | A. Yovine | T. Szczudlo | Siyu Li | T. D. De Pas